Skip to search formSkip to main contentSkip to account menu

SF 2103 A

Known as: SF-2103A 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1986
1986
In vitro evaluation of SF-2103A, a novel carbapenem antibiotic, as a beta-lactamase inhibitor.
SF-2103A, a new carbapenem antibiotic, exhibited a broad antibacterial spectrum and a potent inhibitory activity against a wide… 
1986
1986
Therapeutic effect of SF-2103A, a novel carbapenem antibiotic, in combination with cefotaxime, cefoperazone and other cephalosporins.
Combinations of SF-2103A with cefotaxime, cefoperazone or cefazolin showed synergistic efficacy at a wide range of combination… 
1983
1983
Streptomyces sulfonofaciens sp. nov.
A new species of bacteria is described, for which we propose the name Streptomyces sulfonofaciens. This organism produces a new… 
1981
1981
sf-2103a antibiotic and method for its production
ANTIBIOTICS MEETS THIS FORMULA I: (CF DRAWING IN BOPI) AND PRESENTS THE ULTRAVIOLET ABSORPTION SPECTRUM SHOWN IN FIGURE IT IS… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)